Bioethanol is one of the alternative energy sourced from natural products containing carbohydrates through hydrolysis and fermentation process. Jackfruit seeds is one of the feedstock that contain high carbohydrate content but less utilized. The aims of this study to determine the effect of pH hydrolysis in the process of production bioethanol from jackfruit seeds (Artocarpus heterophyllus) through separate fermentation hydrolysis (SHF) method. The hydrolysis process uses H2SO4 as a hydrolyzing agent. The fermentation process used Saccharomyces cereviceae as a fermentor with a variation of pH 2,3 4 and 5 for 70 hours. The results showed that glucose content of 75% and pH 3 was the optimum pH of fermentation with the content of bioethanol 57.94%. The fermentation stage has an important role in increasing the levels of glucose and bioethanol in linear. The content of glucose and bioethanol of jackfruit seeds showed a great potential for development as the feedstock in bioethanol production.
1 October 2019 in Journal of Physics: Conference Series
Moringa (Moringa oleifera) and Celery (Apium graveolens L) are vegetables and medicinal plants that have excellent benefits for health. The content of secondary metabolites that are very diverse in these two plants has the potential to be developed in other fields. This study aimed to determine the content of secondary metabolites and antioxidant activity of ethanol extract of moringa and celery leaves. The phytochemical analysis using the qualitative parameters of flavonoids, alkaloids, tannins, saponins, phenols, and steroids, and antioxidant activity was determined by the DPPH method. The results showed that moringa leaves contained considerable flavanoid, saponin, tannin, and alkaloid compounds while celery leaves contained fewer flavonoid, saponins, tannins, and alkaloids. Results of the antioxidant activity assay showed that moringa leaf extract had the highest activity with an IC50 value of 248.85 μg/mL while the formulation of moringa-celery (1: 1) had the lowest activity with an IC50 value of 1451.86 μg/mL. These results showed that the antioxidant activity of moringa leaf extract had better antioxidant activity than the moringa-celery extract formulation.
1 October 2019 in Journal of Physics: Conference Series
Controlling of postprandial hyperglycemia using α-glucosidase inhibitors is one of the therapeutic approaches for the treatment of type 2 diabetes. Collagen hydrolysate, as an α-glucosidase inhibitor has not been reported. Therefore, This study intends to evaluate the activity and kinetics of inhibition of collagen hydrolysate against the α-glucosidase enzyme. Collagen hydrolysate was prepared from Thunnus albacares bone enzymatically using bacterial collagenase at hydrolysis times (0; 0.5; 1; 2; 3; 4; 5 and 6 h). The type of inhibition was determined by enzyme kinetics analysis. Collagen hydrolysate obtained at hydrolysis time of 1 h has the highest inhibitory activity of 24.47 %. Based on enzyme kinetics analysis, collagen hydrolysate showed a show a type of competitive inhibition. These results revealed that collagen hydrolysate has the potential as a natural antidiabetic in controlling blood glucose levels in type 2 diabetes.
13 March 2018 in Journal of Physics: Conference Series
The pandemic of COVID-19 caused by SARS-CoV-2 has made a worldwide health emergency. Despite the fact that current vaccines are readily available, several SARSCoV-2 variants affecting the existing vaccine are to be less effective due to the mutations in the structural proteins. Furthermore, the appearance of the new variants cannot be easily predicted in the future. Therefore, the attempts to construct new vaccines or to modify the current vaccines are still pivotal works for preventing the spread of the virus. In the present investigation, the computational analysis through immunoinformatics, molecular docking, and molecular dynamics (MD) simulation is employed to construct an effective vaccine against SARS-CoV2. The structural proteins of SARS-CoV2 are utilized to create a multiepitope-based vaccine (MEV). According to our findings presented by systematic procedures in the current investigation, the MEV construct may be able to trigger a strong immunological response against the virus. Therefore, the designed MEV could be a potential vaccine candidate against SARS-CoV-2, and also it is expected to be effective for other variants.